M. Schroeder et Mj. Mass, CPG METHYLATION INACTIVATES THE TRANSCRIPTIONAL ACTIVITY OF THE PROMOTER OF THE HUMAN P53 TUMOR-SUPPRESSOR GENE, Biochemical and biophysical research communications, 235(2), 1997, pp. 403-406
Alterations of the methylation patterns of DNA are common in cancer ce
lls and could conceivably comprise a subset of causal events in the ca
rcinogenesis process. Although it has previously been shown that methy
lation of CpG islands in the 5'-control regions of tumor suppressor ge
nes such as pie, Von Hippel-Lindau (VHL) syndrome gene, and the retino
blastoma (RB) gene can suppress expression and function of these gene
products, the elements that control the expression of the p53 gene hav
e not been examined in detail. In this study me examined the effect of
CpG methylation in a region of the p53 promoter containing major tran
scription start sites. A region of the p53 promoter (from -199 to +142
) containing 15 CpG dinucleotides was placed in a pCAT reporter plasmi
d and reporter activity was assessed in host CV-1 cells. We show for t
he first time that transcriptional activation of the p53 tumor suppres
sor gene, as assessed by a reporter plasmid construct, can be down-reg
ulated by cytosine methylation in the basal promoter region. We believ
e these data suggest a role for methylation of CpG; sequences in the r
egulation of transcription of p53. This implies that the tumor suppres
sor gene p53 could, therefore, contribute to carcinogenesis by inactiv
ation via methylation of a key element in cell cycle control. (C) 1997
Academic Press.